The DOI matches its Crossref record; 44 of the 44 references it cites were found in a registry or an index.
An estimate of the global prevalence and incidence of herpes simplex virus type 2 infection
Open accessAbstract
OBJECTIVE: To estimate the global prevalence and incidence of herpes simplex virus type 2 (HSV-2) infection in 2003. METHODS: A systematic review was undertaken of published seroprevalence surveys describing the prevalence or incidence of HSV-2 by age and gender. For each of 12 regions, pooled prevalence values by age and gender were generated in a random-effect model. HSV-2 incidence was then estimated from these pooled values using a constant-incidence model. Values of the HSV-2 seroprevalence from the model fits were applied to the total population to estimate the numbers of people infected. FINDINGS: The total number of people aged 15-49 years who were living with HSV-2 infection worldwide in 2003 is estimated to be 536 million, while the total number of people who were newly infected with HSV-2 in 2003 is estimated to be 23.6 million. While the estimates are limited by poor availability of data, general trends are evident. For example, more women than men were infected, and the number infected increased with age. Although prevalence varied substantially by region, predicted prevalence was mostly higher in developing regions than developed regions. CONCLUSION: The prevalence of HSV-2 is relatively easy to measure since infection is lifelong and has a specific serological test. The burden of disease is less easy to quantify. Despite the often sparse data on which these estimates are based, it is clear that HSV-2 infection is widespread. The dramatic differences in prevalence between regions are worthy of further exploration.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Freeman, E. E., Weiss, H. A., Glynn, J. R., Cross, P. L., Whitworth, J. A., & Hayes, R. J. (2006) · AIDS · doi:10.1097/01.aids.0000198081.09337.a7 · Cited by 1,192
Herpes Simplex Virus Type 2 in the United States, 1976 to 1994
Fleming, D. T., McQuillan, G. M., Johnson, R. E., Nahmias, A. J., Aral, S. O., Lee, F. K., & St. Louis, M. E. (1997) · New England Journal of Medicine · doi:10.1056/nejm199710163371601 · Cited by 1,189
Royce, R. A., Seña, A., Cates, W., & Cohen, M. S. (1997) · New England Journal of Medicine · doi:10.1056/nejm199704103361507 · Cited by 1,065
Concurrent partnerships and the spread of HIV
Morris, M., & Kretzschmar, M. (1997) · AIDS · doi:10.1097/00002030-199705000-00012 · Cited by 976
Age‐Specific Prevalence of Infection with Herpes Simplex Virus Types 2 and 1: A Global Review
Smith, J. S., & Robinson, N. J. (2002) · The Journal of Infectious Diseases · doi:10.1086/343739 · Cited by 885
The Acquisition of Herpes Simplex Virus during Pregnancy
Brown, Z. A., Selke, S., Zeh, J., Kopelman, J., Maslow, A., Ashley, R. L., Watts, D. H., Berry, S., Herd, M., & Corey, L. (1997) · New England Journal of Medicine · doi:10.1056/nejm199708213370801 · Cited by 782
Sexual and reproductive health: a matter of life and death.
Glasier, A., Gülmezoglu, A. M., Schmid, G. P., Moreno, C. G., & Van Look, P. F. (2006) · The Lancet · doi:10.1016/s0140-6736(06)69478-6 · Cited by 700
Wald, A., & Link, K. (2002) · The Journal of Infectious Diseases · doi:10.1086/338231 · Cited by 691
Sexual mixing patterns and sex-differentials in teenage exposure to HIV infection in rural Zimbabwe
Gregson, S., Nyamukapa, C. A., Garnett, G. P., Mason, P. R., Zhuwau, T., Caraël, M., Chandiwana, S. K., & Anderson, R. M. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08780-9 · Cited by 583
Sero-epidemiological and -sociological patterns of herpes simplex virus infection in the world.
Nahmias, A. J., Lee, F. K., & Beckman-Nahmias, S. (1990) · PubMed · Cited by 531
Cited by
Epidemiology of Prostate Cancer
Rawla, P. (2019) · World Journal of Oncology · doi:10.14740/wjon1191 · Cited by 2,776
Herpes simplex virus: global infection prevalence and incidence estimates, 2016
James, C., Harfouche, M., Welton, N. J., Turner, K. M., Abu-Raddad, L. J., Gottlieb, S. L., & Looker, K. J. (2020) · Bulletin of the World Health Organization · doi:10.2471/blt.19.237149 · Cited by 791
Self-citationLooker, K. J., Magaret, A. S., May, M. T., Turner, K. M. E., Vickerman, P., Gottlieb, S. L., & Newman, L. M. (2015) · PLOS ONE · doi:10.1371/journal.pone.0140765 · Cited by 644
Self-citationLactobacillus species as biomarkers and agents that can promote various aspects of vaginal health
Petrova, M. I., Lievens, E., Malik, S., Imholz, N., & Lebeer, S. (2015) · Frontiers in Physiology · doi:10.3389/fphys.2015.00081 · Cited by 523
Global Estimates of Prevalent and Incident Herpes Simplex Virus Type 2 Infections in 2012
Looker, K. J., Magaret, A. S., Turner, K. M. E., Vickerman, P., Gottlieb, S. L., & Newman, L. M. (2015) · PLoS ONE · doi:10.1371/journal.pone.0114989 · Cited by 519
Self-citationHerpes Simplex Epithelial and Stromal Keratitis: An Epidemiologic Update
Farooq, A. V., & Shukla, D. (2012) · Survey of Ophthalmology · doi:10.1016/j.survophthal.2012.01.005 · Cited by 479
Bernstein, D. I., Bellamy, A. R., Hook, E. W., Levin, M. J., Wald, A., Ewell, M. G., Wolff, P. A., Deal, C. D., Heineman, T. C., Dubin, G., et al. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cis891 · Cited by 348
Applications of gold nanoparticles in virus detection
Draz, M. S., & Shafiee, H. (2018) · Theranostics · doi:10.7150/thno.23856 · Cited by 342
Recent clinical experience with vaccines using MPL- and QS-21-containing Adjuvant Systems
Garçon, N., & Van Mechelen, M. (2011) · Expert Review of Vaccines · doi:10.1586/erv.11.29 · Cited by 314
Tronstein, E. (2011) · JAMA · doi:10.1001/jama.2011.420 · Cited by 298
Torres, N. I., Noll, K. S., Xu, S., Li, J., Huang, Q., Sinko, P. J., Wachsman, M. B., & Chikindas, M. L. (2013) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-012-9123-x · Cited by 122
Polymer nanoparticles encapsulating siRNA for treatment of HSV-2 genital infection
Steinbach, J. M., Weller, C. E., Booth, C. J., & Saltzman, W. M. (2012) · Journal of Controlled Release · doi:10.1016/j.jconrel.2012.06.008 · Cited by 113
Messenger RNA-Based Vaccines Against Infectious Diseases
Alameh, M.-G., Weissman, D., & Pardi, N. (2020) · Current Topics in Microbiology and Immunology · doi:10.1007/82_2020_202 · Cited by 96
Tenofovir gel for the prevention of herpes simplex virus Type 2 infection.
Abdool Karim, S. S., Abdool Karim, Q., Kharsany, A. B. M., Baxter, C., Grobler, A. C., Werner, L., Kashuba, A., Mansoor, L. E., Samsunder, N., Mindel, A., et al. (2015) · New England Journal of Medicine · doi:10.1056/nejmoa1410649 · Cited by 92
Metadata
- Authors
- Looker, K.
- Venue
- Bulletin of the World Health Organization
- Publisher
- WHO Press
- Published
- 2008-10-01
- Volume
- 86
- Issue
- 10
- Pages
- 805-812
- ISSN
- 0042-9686 (ISSN-L)
- OpenAlex
- W2122452548
- Cited by
- 493
- References
- 44
- FWCI
- 18.18
- Type
- journal article
- Language
- en
- Open access
- diamond
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.